Moderna’s COVID-19 Vaccine 94.5% Effective in Late Stage Trials
on November 16, 2020
27 Comments
Moderna's vaccine to protect people from COVID-19 has an efficacy of 94.5% in late-stage trials.
The news came a week after Pfizer announced its vaccine is 90% effective.





